Significant Contract Wins
13 February 2018 – Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce two significant new contracts with hospital providers in the US. Both hospital providers are new customers to Craneware.
The first contract with a large blue chip healthcare provider, sees Craneware’s Value Cycle products being deployed across this organisation’s 20 hospitals. Craneware’s solutions will be an integral part of this provider’s major system change, helping to ensure revenue integrity during the initiative and beyond. This contract is expected to deliver c$5m of revenue over its initial multi-year term.
The second contract win with an innovative surgical hospital is for the provision of Craneware’s suite of products as part of its strategic growth plans, deploying multiple Craneware solutions, including the Trisus Platform and Trisus Claims Informatics. This provider is focused on improving all aspects of its value cycle. This multi-year contract is expected to deliver c$3.5m of revenue over its initial term.
In accordance with the Company’s revenue recognition policy, the majority of the revenue resulting from these two contracts will be recognised over future periods, adding to the Group’s long term visibility of revenue under contract, supporting ongoing financial performance.
Keith Neilson, CEO of Craneware plc, commented, “These contract wins confirm that the positive momentum and financial success we reported in the first half of the year has continued into the second half.
“This is further evidence of the strategic importance and value that Craneware’s solutions can bring to all sizes and complexities of hospital healthcare providers, as they look to address the challenges they face with the ongoing evolution of the US Healthcare market.
“This continued momentum across the entire business, combined with the strength of our solution set, means we are well positioned to support our customers in the new era of value-based care and deliver increasing stakeholder value.”
For further information, please contact:
- +44 (0)20 7418 8900
- Dan Webster
- Adrian Trimmings
- George Sellar
- +44 (0)208 004 4217
- Caroline Forde
- Hilary Buchanan
- Robyn Fisher
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (“MAR”). Upon the publication of this announcement via a Regulatory Information Service (“RIS”), this inside information is now considered to be in the public domain.
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
You might also like...
Aug 1, 2018 | Announcements
1 August 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the appointment of Investec Bank plc as the Company's Joint Broker with immediate effect. Peel Hunt...read more
Jul 10, 2018 | Announcements
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018. The Group is pleased to announce continued outstanding...read more
Apr 17, 2018 | Announcements
Schedule 6, Block Admission Period to 15 April 2018 This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month...read more